SPOTLIGHT: Inventor wins $431M from Boston Sci

A Texas jury ruled that Boston Scientific's drug-coated stents violate a 1997 patent and awarded $431 million to patent holder Dr. Bruce N. Saffran. Confident it can win on appeal, the company won't set aside money to pay the damages. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.